Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors
by Menzel, Michael (Author)
, Kirchner, Martina (Author)
, Kluck, Klaus (Author)
, Ball, Markus (Author)
, Beck, Susanne (Author)
, Allgäuer, Michael (Author)
, Assmann, Christin (Author)
, Schnorbach, Johannes (Author)
, Volckmar, Anna-Lena (Author)
, Tay, Timothy Kwang Yong (Author)
, Goldschmid, Hannah (Author)
, Tan, Daniel SW (Author)
, Thomas, Michael (Author)
, Kazdal, Daniel (Author)
, Budczies, Jan (Author)
, Stenzinger, Albrecht (Author)
, Christopoulos, Petros (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource